A polymeric micelle magnetic resonance imaging (MRI) contrast agent reveals blood–brain barrier (BBB) permeability for macromolecules in cerebral ischemia‐reperfusion injury

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-05-10

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.jconrel.2017.03.020PMID 28322975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.

  2016cited by this paper
• Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.

  2016cited by this paper
• Blood—Brain Barrier Breakdown Involves Four Distinct Stages of Vascular Damage in Various Models of Experimental Focal Cerebral Ischemia

  2015cited by this paper
• Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans

  2014cited by this paper
• Clinical Outcomes Strongly Associated With the Degree of Reperfusion Achieved in Target Mismatch Patients: Pooled Data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution Studies

  2013cited by this paper
• MRI Blood–Brain Barrier Permeability Measurements to Predict Hemorrhagic Transformation in a Rat Model of Ischemic Stroke

  2012cited by this paper
• MRI of Blood–Brain Barrier Permeability in Cerebral Ischemia

  2012cited by this paper
• Challenges in drug delivery to the brain: nature is against us.

  2012cited by this paper
• Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin.

  2012cited by this paper
• Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke

  2012cited by this paper
• Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

  2011cited by this paper
• Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence

  2011cited by this paper
• Safety of Low-Frequency Transcranial Ultrasound in Permanent Middle Cerebral Artery Occlusion in Spontaneously Hypertensive Rats

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Validation of In Vivo Magnetic Resonance Imaging Blood–Brain Barrier Permeability Measurements by Comparison With Gold Standard Histology

  2011cited by this paper
• Accumulation of macromolecules in brain parenchyma in acute phase of cerebral infarction/reperfusion.

  2010cited by this paper
• Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Estimating Blood and Brain Concentrations and Blood-to-Brain Influx by Magnetic Resonance Imaging with Step-Down Infusion of Gd-DTPA in Focal Transient Cerebral Ischemia and Confirmation by Quantitative Autoradiography with Gd-[14C]DTPA

  2009cited by this paper
• Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.

  2009cited by this paper
• Spatiotemporal Correlations between Blood-Brain Barrier Permeability and Apparent Diffusion Coefficient in a Rat Model of Ischemic Stroke

  2009cited by this paper
• Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.

  2009cited by this paper
• Cerebral Ischemia–Reperfusion Injury in Rats—A 3 T MRI Study on Biphasic Blood–Brain Barrier Opening and the Dynamics of Edema Formation

  2009cited by this paper
• Identification of Variations in Blood-Brain Barrier Opening After Cerebral Ischemia by Dual Contrast-Enhanced Magnetic Resonance Imaging and T1sat Measurements

  2008cited by this paper
• Neuroprotection for ischemic stroke: past, present and future.

  2008cited by this paper
• Acute Leakage Patterns of Fluorescent Plasma Flow Markers after Transient Focal Cerebral Ischemia Suggest Large Openings in Blood‐Brain Barrier

  2008cited by this paper
• Blood-brain barrier tight junction permeability and ischemic stroke.

  2008cited by this paper
• Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

  2007cited by this paper
• Pros and Cons of the Liposome Platform in Cancer Drug Targeting

  2006cited by this paper
• Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat.

  2006cited by this paper
• Quantitative Evaluation of BBB Permeability after Embolic Stroke in Rat Using MRI

  2005cited by this paper
• Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats

  2004cited by this paper
• The blood-brain barrier to protein tracers in focal cerebral ischemia and infarction caused by occlusion of the middle cerebral artery

  2004cited by this paper
• Identifying Thresholds for Penumbra and Irreversible Tissue Damage

  2004cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Estrogen-Like Compounds for Ischemic Neuroprotection

  2004cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Patlak plots of Gd‐DTPA MRI data yield blood–brain transfer constants concordant with those of 14C‐sucrose in areas of blood–brain opening

  2003cited by this paper
• Magnetic Resonance Imaging Characterization of Hemorrhagic Transformation of Embolic Stroke in the Rat

  2002cited by this paper
• Prediction of Hemorrhagic Transformation After Thrombolytic Therapy of Clot Embolism: An MRI Investigation in Rat Brain

  2002cited by this paper
• Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats

  2002cited by this paper
• Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery.

  2002cited by this paper
• Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system.

  1999cited by this paper
• Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

  1998cited by this paper
• Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Reversible Focal Ischemic Injury Demonstrated by Diffusion‐Weighted Magnetic Resonance Imaging in Rats

  1992cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Exploring molecular interactions of drugs in different biologically active solvents: A comprehensive review for safe and efficient drug delivery systems.

  2026cites this paper
• Ischemic stroke nanomedicine.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Targeting of Nanoparticles towards Blood–Brain Barrier with a Potential for the Treatment of Cerebrovascular Disorders: A Systematic Review (2017–2023)

  2025cites this paper
• Targeted Nanotheranostics: Integration of Preclinical MRI and CT in the Molecular Imaging and Therapy of Advanced Diseases

  2024cites this paper
• Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis

  2024cites this paper
• Surface-engineered quantum dot nanocomposites for neurodegenerative disorder remediation and avenue for neuroimaging

  2024cites this paper
• Controlled Drug Release Systems for Cerebrovascular Diseases

  2024cites this paper
• Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

  2024cites this paper
• Cholinergic signaling of muscarinic receptors directly involves in the neuroprotection of muscone by inducing Ca2+ antagonism and maintaining mitochondrial function.

  2023cites this paper
• Nanomaterial-Based Drug Delivery Systems for Ischemic Stroke

  2023influential citation
• Strategies for Targeted Delivery via Structurally Variant Polymeric Nanocarriers

  2023cites this paper
• Advances in designing of polymeric micelles for biomedical application in brain related diseases.

  2022cites this paper
• Progress in Polymeric Micelles as Viable Wagons for Brain Targeting.

  2022cites this paper
• Pegylated poly(amino acid) copolymers for delivery of magnetic nanoparticles

  2022influential citation
• Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases

  2022cites this paper
• Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier

  2022cites this paper
• Enhancing autophagy in Alzheimer's disease through drug repositioning.

  2022cites this paper
• Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature

  2021cites this paper
• Mechanical Thrombectomy in Patients with Acute Ischemic Stroke and ASPECTS ≤5.

  2021cites this paper
• Biocompatible BSA-MnO2 nanoparticles for in vivo timely permeability imaging of blood-brain barrier and prediction of hemorrhage transformation in acute ischemic stroke.

  2021cites this paper
• Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI.

  2021cites this paper
• Nanotheranostics: The Future Remedy of Neurological Disorders

  2021cites this paper
• Nanomaterials‐Mediated Structural and Physiological Modulation of Blood Brain Barrier for Therapeutic Purposes

  2021cites this paper
• Potential nanocarriers for the delivery of drugs to the brain

  2020cites this paper
• Visualising brain capillaries in magnetic resonance images via supramolecular self-assembly.

  2020cites this paper
• Nanocarriers as Potential Drug Delivery Candidates for Overcoming the Blood–Brain Barrier: Challenges and Possibilities

  2020cites this paper
• Clinical Data In Chemical Biology

  2020cites this paper
• The effectiveness of various cytotherapeutic strategies for the treatment of ischemic stroke: a Bayesian network meta-analysis of randomized controlled trials

  2020cites this paper
• Contrast Agents Delivery: An Up-to-Date Review of Nanodiagnostics in Neuroimaging

  2019cites this paper
• MRI micelles self-assembled from synthetic gadolinium-based nano building blocks.

  2019cites this paper
• Neuronanomedicine: An Up-to-Date Overview

  2019cites this paper
• Particularities of Using Contrast Agents in Diagnosis of Stroke

  2019cites this paper
• Superfine Magnetic Resonance Imaging of the Cerebrovasculature Using Self-Assembled Branched Polyethylene Glycol-Gd Contrast Agent.

  2018cites this paper
• QUANTITATIVE MAGNETIC RESONANCE IMAGING FOR CANCER AND NEUROLOGY A Dissertation Presented By

  2018cites this paper
• Ultrasound‐Triggered Delivery of Anticancer Therapeutics from MRI‐Visible Multilayer Microcapsules

  2018cites this paper
• A novel theranostics nanoparticles pGGA-PTX / SPION with bifunction of diagnosis and treatment

  2018cites this paper
• [3. Researches of Drug Delivery System and Theranostics Using Pre-clinical MRI].

  2018cites this paper
• Current Strategies for Brain Drug Delivery

  2018cites this paper
• Blood-Brain Delivery Methods Using Nanotechnology

  2018cites this paper
• 1, 25-D3 Protects From Cerebral Ischemia by Maintaining BBB Permeability via PPAR-γ Activation

  2018cites this paper
• Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke

  2018cites this paper
• Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries.

  2017cites this paper
• Photo Irradiation-Induced Core Crosslinked Poly(ethylene glycol)-block-poly(aspartic acid) Micelles: Optimization of Block Copolymer Synthesis and Characterization of Core Crosslinked Micelles

  2017cites this paper